Sarcoid heart disease

Canadian Journal of Cardiology

Volumn 20, Issue 1, 2004, Pages 89-93

  Syed, Jaffer ^a   Myers, Robert ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cardiomyopathy; Myocarditis; Sudden death

Indexed keywords

AMIODARONE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR;

ARTIFICIAL HEART PACEMAKER; CARDIOVERSION; CONGESTIVE CARDIOMYOPATHY; DEFIBRILLATOR; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART BLOCK; HEART DISEASE; HEART MUSCLE BIOPSY; HEART MUSCLE PERFUSION; HEART VENTRICLE ARRHYTHMIA; HOLTER MONITORING; HUMAN; MEDICAL RESEARCH; MEDLINE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; REVIEW; RISK ASSESSMENT; SARCOIDOSIS; ADULT; AGE DISTRIBUTION; AGED; CANADA; CARDIOMYOPATHY; FEMALE; HOSPITALIZATION; IMMUNOHISTOCHEMISTRY; INCIDENCE; MALE; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY; SEX RATIO; SUDDEN DEATH; SURVIVAL;

ADRENAL CORTEX HORMONES; ADULT; AGE DISTRIBUTION; AGED; BIOPSY, NEEDLE; CARDIOMYOPATHIES; DEATH, SUDDEN, CARDIAC; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; MALE; MIDDLE AGED; ONTARIO; PACEMAKER, ARTIFICIAL; RISK ASSESSMENT; SARCOIDOSIS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL ANALYSIS;

EID: 1442356559     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Mandell BF, Hoffman GS. Rheumatic Diseases and the Cardiovascular System. In: Braunwald E, Zipes DP, Libby P, eds. Heart Disease, 6th edn. Philedelphia: WB Saunders, 2001:2207-8.
2. Hunninghake GW, Costabel U, Ando M, et al. Statement on sarcoidosis. Am J Resp Crit Care Med 1999;160:736-55.
3. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: A clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 1978;58:1204-11.
4. Sharma O, Maheshwari A, Thaker K. Myocardial sarcoid. Chest 1993;103:253-8.
5. Bernstein M, Konzlemann FW, Sidlick DM. Boeck's sarcoid. Report of a case with visceral involvement. Arch Intern Med 1929;44:721-34.
6. Shirani J, Roberts WC. Subepicardial myocardial lesions. Am Heart J 1993;125:1346-52.
7. Felker GM, Hu W, Hare JM, Hruban RH, Baughman KL, Kasper EK. The spectrum of dilated cardiomyopathy. Medicine 1999;78:270-83.
8. Roberts WC, McAllister HA, Ferrans VJ. Sarcoidosis of the heart: A clinicopathologic study of 35 necropsy patients (group I) and review of 78 previously described necropsy patients (group II). Am J Med 1977;36:54-68.
9. Perry A, Vuitch F. Causes of death in patients with sarcoidosis. Arch Pathol Lab Med 1995;119:167-72.
10. Sharma OP. Cardiac and neurologic dysfunction in sarcoidosis. Clin Chest Med 1997;18:813-7.
11. Efferen LS. The challenge of sarcoidosis. Chest 2001;120:697-9.
12. Barst RJ, Ratner SJ. Sarcoidosis and reactive pulmonary hypertension. Arch Intern Med 1985;145:2112-4.
13. Stewart RE, Graham DM, Godfrey GW, Friedman HZ, Das SK, Shea MJ. Rapidly progressive heart failure resulting from cardiac sarcoidosis. Am Heart J 1988;115:1324-6.
14. Sekiguchi M, Numao Y, Imai M, Furuie T, Mikami R. Clinical and histopathological profile of sarcoidosis of the heart and acute idiopathic myocarditis. Concepts through a study employing endomyocardial biopsy. Jpn Circ J 1980;44:249-63.
15. Thunell M, Bjerle P, Stjernberg N. ECG abnormalities in patients with sarcoidosis. Acta Med Scand 1983;213:115-8.
16. Stein E, Jackler I, Stimmel B, Stein W, Siltzbach LE. Asymptomatic electrocardiographic alterations in sarcoidosis. Am Heart J 1973;86:474-7.
17. Thunell M, Bjerle P, Karp K, Stjernberg N. Exercise test in patients with sarcoidosis: The importance of repolarization disturbances. Acta Med Scand 1988;223:69-73.
18. Suzuki T, Kanda T, Kubota S, Imai S, Murata K. Holter monitor as a non-invasive indicator of cardiac involvement in sarcoidosis. Chest 1994:106;1021-4.
19. Sietsema KE, Kraft M, Ginzton L, Sharma OP. Abnormal oxygen uptake responses to exercise in patients with mild pulmonary sarcoidosis. Chest 1992;102:838-45.
20. Gibbons WJ, Levy RD, Nava S, et al. Subclinical cardiac dysfunction in sarcoidosis. Chest 1991;100:44-50.
21. Burstow DJ, Tajik AJ, Bailey KR, DeRemee RA, Taliercio CP. Two-dimensional echocardiographic findings in systemic sarcoidosis. Am J Cardiol 1989;63:478-82.
22. Lewin RF, Mor R, Spitzer S, Arditti A, Hellman C, Agmon J. Echocardiographic evaluation of patients with systemic sarcoidosis. Am Heart J 1985;110:116-22.
23. Matsumori A, Hara M, Nagai S, et al. Hypertrophic cardiomyopathy as a manifestation of cardiac sarcoidosis. Jpn Circ J 2000;64:679-83.
24. Yazaki Y, Isobe M, Hayasaka M, Tanaka M, Fujii T, Sekiguchi M. Cardiac sarcoidosis mimicking hypertrophic cardiomyopathy: Clinical utility of radionuclide imaging for differential diagnosis. Jpn Circ J 1998;62:465-8.
25. Tellier P, Paycha F, Antony I, et al. Reversibility by dipyridamole of thallium-201 myocardial scan defects in patients with sarcoidosis. Am J Med 1988;85:189-93.
26. Yazaki Y, Isobe M, Hiramitsu S, et al. Comparison of clinical features and prognosis of cardiac sarcoidosis and idiopathic dilated cardiomyopathy. Am J Cardiol 1998;82:537-40.
27. Yamamoto N, Gotoh K, Yagi Y, et al. Thallium-201 myocardial SPECT findings at rest in sarcoidosis. Ann Nuc Med 1993;7:97-103.
28. Kinney E, Murthy R, Ascunce G, Donohoe R, Zelis R. Pericardial effusions in sarcoidosis. Chest 1979;76:476-8.
29. Hirose Y, Ishida Y, Hayashida K, et al. Myocardial involvement in patients with sarcoidosis. An analysis of 75 patients. Clin Nucl Med 1994;19:522-6.
30. Chandra M, Silverman ME, Oshinski J, Pettigrew R. Diagnosis of cardiac sarcoidosis aided by MRI. Chest 1996;110:562-5.
31. Inoue S, Shimada T, Murakami Y. Clinical significance of gadolinium-DPTA-enhanced MRI for detection of myocardial lesions in a patient with sarcoidosis. Clin Radiol 1999;54:70-2.
32. Schaedel H, Kirsten D, Schmidt A, Schmidt H, Strauss HJ. Sarcoid heart disease - Results of follow-up investigations. Eur Heart J 1991;12(Suppl D):26-7.
33. Ratner SJ, Fenoglio JJ Jr, Ursell PC. Utility of endomyocardial biopsy in the diagnosis of cardiac sarcoidosis. Chest 1986;90:528-33.
34. Sekiguchi M, Numao Y, Imai M, Furuie T, Mikami R. Clinical and histopathological profile of sarcoidosis of the heart and acute idiopathic myocarditis. Concepts through a study employing endomyocardial biopsy. Jpn Circ J 1980;44:249-63.
35. Uemura A, Morimoto S, Hiramitsu S, Kato Y, Ito T, Hishida H. Histologic diagnostic rate of cardiac sarcoidosis: Evaluation of endomyocardial biopsies. Am Heart J 1999;138:299-302.
36. Lorell B, Alderman EL, Mason JW. Cardiac sarcoidosis. Diagnosis with endomyocardial biopsy and treatment with corticosteroids. Am J Cardiol 1978;42:143-6.
37. Ishikawa T, Kondoh H, Nakagawa S, Koiwaya Y, Tanaka K. Steroid therapy in cardiac sarcoidosis. Chest 1984;85:445-7.
38. Valantine HA, Tazelaar HD, Macoviak J, et al. Cardiac sarcoidosis: Response to steroids and transplantation. J Heart Transplant 1987;6:244-50.
39. Fujita N, Hiroe M, Suzuki Y, et al. A case with cardiac sarcoidosis. Significance of the effect of steroids on the reversion of advanced atrioventricular block and myocardial scintigraphic abnormalities. Heart Vessels Suppl 1990;5:16-8.
40. Shammas RL, Movahed A. Successful treatment of myocardial sarcoidosis with steroids. Sarcoidosis 1994;11:37-9.
41. Demeter SL. Myocardial sarcoidosis unresponsive to steroids: Treatment with cyclophosphamide. Chest 1988;94:202-3.
42. Baughman RP, Ohmichi M, Lower EE. Combination therapy for sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2001;18:133-7.
43. Baughman RP, Lower EE. Infliximab for refractory sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2001;18:70-4.
44. Yee AM, Pochapin MB. Treatment of complicated sarcoidosis with Infliximab anti-tumor necrosis factor-alpha therapy. Ann Intern Med 2001;135:27-31.
45. Oni AA, Hershberger RE, Norman-DJ, et al. Recurrence of sarcoidosis in a cardiac allograft: Control with augmented corticosteroids. J Heart Lung Transplant 1992;11:367-9.
46. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-83.
47. Siebels J, Kuck KH. Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors. Am Heart J 1994;127:1139-44.
48. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933-40.
49. Winters SL, Cohen M, Greenberg S, et al. Sustained ventricular tachycardia associated with sarcoidosis: Assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device. J Am Coll Cardiol 1991;18:937-43.